HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$1.10
Day range
$1.08 - $1.13
Year range
$0.71 - $1.96
Market cap
193.82M USD
Avg Volume
1.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 35.69M | -27.57% |
Operating expense | 26.85M | -16.54% |
Net income | 737.00K | -47.39% |
Net profit margin | 2.06 | -27.46% |
Earnings per share | 0.00 | -100.00% |
EBITDA | 2.16M | 28.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 56.93M | -2.19% |
Total assets | 117.22M | -12.70% |
Total liabilities | 145.87M | -1.37% |
Total equity | -28.64M | — |
Shares outstanding | 175.38M | — |
Price to book | -6.88 | — |
Return on assets | 4.01% | — |
Return on capital | 6.30% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 737.00K | -47.39% |
Cash from operations | -6.24M | 71.52% |
Cash from investing | -6.87M | -136.96% |
Cash from financing | 486.00K | 123.19% |
Net change in cash | -12.63M | -133.55% |
Free cash flow | -8.53M | -6.03% |
About
Founded
1996
Headquarters
Website
Employees
147